|
AGK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.721200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.035000E-01 |
| Normal-vs-Stage2 |
3.749200E-01 |
| Normal-vs-Stage3 |
9.438400E-02 |
| Normal-vs-Stage4 |
9.359600E-01 |
| Stage1-vs-Stage2 |
3.508200E-01 |
| Stage1-vs-Stage3 |
2.634000E-02 |
| Stage1-vs-Stage4 |
8.020600E-01 |
| Stage2-vs-Stage3 |
3.313800E-02 |
| Stage2-vs-Stage4 |
4.254200E-01 |
| Stage3-vs-Stage4 |
2.330800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.351800E-01 |
| Normal-vs-AfricanAmerican |
8.391000E-01 |
| Normal-vs-Asian |
6.662000E-01 |
| Caucasian-vs-AfricanAmerican |
5.876200E-01 |
| Caucasian-vs-Asian |
3.805800E-01 |
| AfricanAmerican-vs-Asian |
9.218200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.491200E-01 |
| Normal-vs-Female |
7.661800E-01 |
| Male-vs-Female |
5.799600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.079800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.446800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.670200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.790800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.464600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.895000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.815200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.448600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.796400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.487600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.648500E-02 |
| Classical-VS-Follicular |
1.565430E-01 |
| Classical-VS-Other |
9.703600E-01 |
| Classical-VS-Normal |
8.512600E-01 |
| Tall-VS-Follicular |
3.904800E-03 |
| Tall-VS-Other |
2.524000E-01 |
| Tall-VS-Normal |
4.785800E-02 |
| Follicular-VS-Other |
6.478600E-01 |
| Follicular-VS-Normal |
2.235000E-01 |
| Other-VS-Normal |
9.738200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.625400E-01 |
| Normal-vs-N1 |
5.209800E-01 |
| N0-vs-N1 |
7.138600E-01 |
|
|
